Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Queensland Health
QuintilesIMS
Cerilliant
Moodys
Boehringer Ingelheim
McKinsey
US Department of Justice
Covington
Accenture

Generated: February 23, 2018

DrugPatentWatch Database Preview

ANTABUSE Drug Profile

« Back to Dashboard

When do Antabuse patents expire, and what generic alternatives are available?

Antabuse is a drug marketed by Odyssey Pharms and Teva Womens and is included in three NDAs.

The generic ingredient in ANTABUSE is disulfiram. There are seven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the disulfiram profile page.
Drug patent expirations by year for ANTABUSE
Pharmacology for ANTABUSE
Medical Subject Heading (MeSH) Categories for ANTABUSE

US Patents and Regulatory Information for ANTABUSE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Odyssey Pharms ANTABUSE disulfiram TABLET;ORAL 088482-001 Dec 8, 1983 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Womens ANTABUSE disulfiram TABLET;ORAL 007883-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Odyssey Pharms ANTABUSE disulfiram TABLET;ORAL 088483-001 Dec 8, 1983 AB RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Womens ANTABUSE disulfiram TABLET;ORAL 007883-003 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Fish and Richardson
Moodys
Deloitte
Colorcon
Cipla
AstraZeneca
UBS
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot